The information provided on this page is for reference only. Please refer to the latest information published by the partner company.
GenieBiome, a biotechnology spinout from The Chinese University of Hong Kong was founded by world-renowned clinician-scientists and supported by a multidisciplinary team of experts in microbiology, metagenomics, bioinformatics, disease biomarkers, food technology, clinical trials, IP development and commercialization. For over a decade, our team has pioneered the use of microbiome with evidence-based science to tackle a myriad of diseases.
Our precision portfolio of G-NiiB includes diagnostic and risk prediction tests, next generation microbiome precision formula, and precision medicine tailored for the Asian population.